Scientific Reports · 2020 · 46 citations · 30 references
MedicineGynecologyOncologyCancer ScreeningEarly DetectionMolecular OncologyBiomarker DiscoveryBiomarker ValidationCancer BiomarkersCancer Molecular DiagnosticsCervical CancerTumor MarkersCirculating Microrna DetectionEarly Cancer Detection MarkersIndependent Cohort ValidationIndependent ValidationSensitivitySerum BiomarkersSerum Protein BiomarkersTumor Marker Panels
Recently, we have been seeing emerging applications of non-invasive approaches using serum biomarkers including miRNA and proteins in detection of multiple cancers. Currently, majority of these methods only use solitary type of biomarkers, which often lead to non-satisfactory sensitivity and specificity in clinical applications. To this end, we established a unique biomarker panel in this study, which determined both squamous cell carcinoma antigen (SCC Ag) degree and miRNA-29a, miRNA-25, miRNA-486-5p levels in blood for detection of early-stage cervical cancer. We designed our study with two phases: a biomarker discovery phase, followed by an independent validation phase. In total of 140 early-stage cervical cancer patients (i.e., AJCC stage I and II) and 140 healthy controls recruited in the biomarker discovery phase, we achieved sensitivity of 88.6% and specificity of 92.9%. To further assess the predictive power of our panel, we used it to an independent patient cohort that consisted of 60 early-stage cervical cancer individuals as well as 60 healthy controls, and successfully achieved both high sensitivity (80.0%) and high specificity (96.7%). Our study indicated combining analyses of multiple serum biomarkers could improve the accuracy of non-invasive detection of early-stage cervical cancer, and potentially serve as a new liquid biopsy approach for detecting early-stage cervical cancer.
30
Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen, Lu Li, Yuxuan Wang et al. · Science · 2018 · 2.8K citations
Medicine, Oncology, Cancer Screening +16
A MicroRNA Expression Signature for Cervical Cancer Prognosis
Xiaoxia Hu, Julie K. Schwarz, James S. Lewis et al. · Cancer Research · 2010 · 317 citations · Full text
Medicine, Cancer Biology, Oncology +17
Altered MicroRNA Expression in Cervical Carcinomas
Jeong‐Won Lee, Chel Hun Choi, Jung‐Joo Choi et al. · Clinical Cancer Research · 2008 · 308 citations